Layne Norton 00:01:49 Sponsors: Mateina, Eight Sleep, Maui Nui 00:06:39 Science-Based Evidence, Mechanism vs
Our pharmacists can talk through your symptoms and help you decide if a B12 injection is right for you
In T2DM patients at high risk for cardiovascular events in the LEADER clinical trial, those who received the GLP-1 RA liraglutide experienced fewer events in the primary composite outcome (the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke) than the placebo group, with a median follow-up of 42 months
Whilst it can affect any patient group, it should be especially suspected in those with known active peptic ulcer disease , a recent history of NSAID use or steroid use , or known H
See below for a list of the other episodes in the series
Some clients may taper off the medication, while others might continue on a maintenance dose